HIF1A and hepatocellular carcinoma: Tan et al. showed that the overexpression of circ-EPHB4 resulted in the inhibition of hepatocellular carcinoma (HCC) progression by regulating the HIF-1α expression and the phosphatidylinositol 3 kinase (PI3K)-protein kinase B (AKT) pathways [43].